Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86,559,040
-
Number of holders
-
27
-
Total 13F shares, excl. options
-
9,443,951
-
Shares change
-
+9,443,951
-
Total reported value, excl. options
-
$125,631,000
-
Value change
-
+$125,631,000
-
Number of buys
-
27
-
Price
-
$13.32
Significant Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q1 2016
27 filings reported holding SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share as of Q1 2016.
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) has 27 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,443,951 shares
of 86,559,040 outstanding shares and own 10.91% of the company stock.
Largest 10 shareholders include MPM ASSET MANAGEMENT LLC (2,168,691 shares), FMR LLC (2,094,464 shares), WELLINGTON MANAGEMENT GROUP LLP (1,318,028 shares), ORBIMED ADVISORS LLC (757,365 shares), EcoR1 Capital, LLC (510,829 shares), JENNISON ASSOCIATES LLC (460,892 shares), BLACKROCK ADVISORS LLC (308,693 shares), TIVERTON ASSET MANAGEMENT LLC (288,750 shares), Redmile Group, LLC (263,000 shares), and Boxer Capital, LLC (234,220 shares).
This table shows the top 27 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.